Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating on DB107-RRV and DB107-FC with radiation therapy, with or without temozolomide, for high-grade glioma including MGMT unmethyla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DB107-FC
  • DB107-RRV
  • Temodar (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: High Grade Glioma, MGMT-Unmethylated Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING